pillbase.ru

hyaluronidase (human recombinant)

Synonyms

—

Identifiers
DRUGBANK
DB06205
CHEMBL
CHEMBL1201718
Registered products
  • Darzalex Faspro
    INJECTION · DARATUMUMAB 1800 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 U/15mL
    57894-503
    Janssen Biotech, Inc.
  • HYALURONIDASE
    INJECTION, SOLUTION · HYALURONIDASE (HUMAN RECOMBINANT) 150 [USP'U]/mL
    51662-1555
    HF Acquisition Co LLC, DBA HealthFirst
  • HYLENEX Recombinant
    INJECTION, SOLUTION · HYALURONIDASE (HUMAN RECOMBINANT) 150 [USP'U]/mL
    18657-117
    Antares Pharma, Inc.
  • Herceptin Hylecta
    INJECTION, SOLUTION · TRASTUZUMAB 600 mg/5mL, HYALURONIDASE (HUMAN RECOMBINANT) 10000 U/5mL
    50242-077
    Genentech, Inc.
  • OPDIVO QVANTIG
    INJECTION, SOLUTION · NIVOLUMAB 120 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    0003-3120
    E.R. Squibb & Sons, L.L.C.
  • OPDIVO QVANTIG
    INJECTION, SOLUTION · NIVOLUMAB 120 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    0003-6120
    E.R. Squibb & Sons, L.L.C.
  • Ocrevus Zunovo
    INJECTION, SOLUTION · OCRELIZUMAB 920 mg/23mL, HYALURONIDASE (HUMAN RECOMBINANT) 23000 U/23mL
    50242-554
    Genentech, Inc.
  • Phesgo
    INJECTION, SOLUTION · PERTUZUMAB 600 mg/10mL, TRASTUZUMAB 600 mg/10mL, HYALURONIDASE (HUMAN RECOMBINANT) 20000 U/10mL
    50242-260
    Genentech, Inc.
  • Phesgo
    INJECTION, SOLUTION · PERTUZUMAB 1200 mg/15mL, TRASTUZUMAB 600 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 U/15mL
    50242-245
    Genentech, Inc.
  • Rituxan Hycela
    INJECTION, SOLUTION · RITUXIMAB 120 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    50242-109
    Genentech, Inc.
  • Rituxan Hycela
    INJECTION, SOLUTION · RITUXIMAB 120 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    50242-108
    Genentech, Inc.
  • Rybrevant Faspro
    INJECTION · AMIVANTAMAB 2240 mg/14mL, HYALURONIDASE (HUMAN RECOMBINANT) 28000 mg/14mL
    57894-514
    Janssen Biotech, Inc.
  • Rybrevant Faspro
    INJECTION · AMIVANTAMAB 2400 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 mg/15mL
    57894-515
    Janssen Biotech, Inc.
  • Rybrevant Faspro
    INJECTION · AMIVANTAMAB 3520 mg/22mL, HYALURONIDASE (HUMAN RECOMBINANT) 44000 mg/22mL
    57894-522
    Janssen Biotech, Inc.
  • Rybrevant Faspro
    INJECTION · AMIVANTAMAB 1600 mg/10mL, HYALURONIDASE (HUMAN RECOMBINANT) 20000 mg/10mL
    57894-510
    Janssen Biotech, Inc.
  • Tecentriq Hybreza
    INJECTION · ATEZOLIZUMAB 1875 mg/15mL, HYALURONIDASE (HUMAN RECOMBINANT) 30000 U/15mL
    50242-933
    Genentech, Inc.
  • VYVGART Hytrulo
    INJECTION, SOLUTION · EFGARTIGIMOD ALFA 180 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    73475-3102
    argenx US
  • VYVGART Hytrulo
    INJECTION, SOLUTION · EFGARTIGIMOD ALFA 200 mg/mL, HYALURONIDASE (HUMAN RECOMBINANT) 2000 U/mL
    73475-1221
    argenx US
Control by country
  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-9417-737b-bec2-4f941d0ce65e,01a1209b-218c-7cf1-a072-f9449bb3795a;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Data provenance
names.enwikidata—
identifiers.DRUGBANK—DB06205
identifiers.CHEMBL—CHEMBL1201718